Home » Stocks » EW » Financials » Income Statement

Edwards Lifesciences Corporation (EW)

Stock Price: $85.61 USD 0.91 (1.07%)
Updated November 24, 4:00 PM EST - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January-December.
Year201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue4,3483,7233,4352,9642,4942,3232,0461,9001,6791,4471,3211,2381,0911,037998932861704692804905865879837
Revenue Growth16.79%8.37%15.91%18.85%7.35%13.56%7.68%13.17%16.01%9.51%6.76%13.44%5.22%3.92%7.13%8.25%22.23%1.72%-13.9%-11.18%4.62%-1.59%5.02%-
Cost of Revenue1,114939875797617626517491490408399420378374375370359299324423466466463442
Gross Profit3,2342,7832,5602,1661,8771,6971,5291,4091,1891,039922818713663623561501405368381439399416395
Selling, General & Admin1,2421,089991905851858733697642550509481418376349320290228203216233222211194
Research & Development75362255344238334732329124620417613912211499.0087.0072.8065.2055.0054.4055.0056.0053.0049.00
Other Operating Expenses98.00323-12.7067.107.00-669.70-45.2030.4021.6022.70-63.8025.1023.30-4.5049.4011137.1070.7033.3034534.0034.0016725.00
Operating Expenses2,0932,0341,5311,4141,2415351,0111,019910777621645564486497517400364292615322312431268
Operating Income1,1417501,0297526361,16351839027926230217314917812643.9010141.1076.90-23511787.00-15.00127
Interest Expense / Income20.7029.9023.2019.2017.2017.209.804.403.102.402.707.209.1010.5012.3015.2013.2011.5022.9020.00----
Other Expense / Income-46.50-41.70-28.80-4.80-3.701.30-3.30-3.10-8.20-9.00-5.301.60-9.60-5.10-2.80-1.40-4.70-26.4063.903.804.00-6.000.000.00
Pretax Income1,1677611,0357386221,14451138828426830416415017211730.1092.8056.00-9.90-25811393.00-15.00127
Income Tax12039.2045116812833312296.7046.9050.2075.3035.5036.8041.8037.4028.4013.800.301.5013.3031.0031.0037.0040.00
Net Income1,04772258457049581138929223721822912911313179.301.7079.0055.70-11.40-27282.0062.00-52.0087.00
Shares Outstanding (Basic)625628633639647639670689688682675670688702715715709708707704697---
Shares Outstanding (Diluted)637641648653661651683710716715705715752767748744733736707-----
Shares Change-0.43%-0.81%-0.99%-1.16%1.17%-4.66%-2.79%0.26%0.79%1.07%0.72%-2.53%-2.05%-1.85%0%0.85%0.17%0.17%0.4%1%----
EPS (Basic)1.681.150.920.890.771.270.580.420.350.320.340.190.160.190.11-0.110.08-0.02-----
EPS (Diluted)1.641.130.900.870.751.250.570.410.330.310.330.180.160.180.11-0.110.08-0.02-----
EPS Growth45.79%25.22%3.45%16%-39.86%118.77%39.02%24.24%8.2%-6.15%77.6%17.31%-10.86%65.09%3433.33%-97.2%40.79%-------
Free Cash Flow Per Share1.481.101.320.830.691.480.550.370.340.290.150.150.230.250.120.190.150.160.090.130.19---
Gross Margin74.4%74.8%74.5%73.1%75.2%73.1%74.7%74.2%70.8%71.8%69.8%66.1%65.3%64%62.5%60.3%58.2%57.5%53.2%47.3%48.5%46.1%47.3%47.2%
Operating Margin26.2%20.1%30.0%25.4%25.5%50.0%25.3%20.5%16.6%18.1%22.8%14.0%13.7%17.1%12.6%4.7%11.8%5.8%11.1%-29.2%12.9%10.1%-1.7%15.2%
Profit Margin24.1%19.4%17%19.2%19.8%34.9%19%15.3%14.1%15.1%17.3%10.4%10.4%12.6%7.9%0.2%9.2%7.9%-1.6%-33.8%9.1%7.2%-5.9%10.4%
FCF Margin21.3%18.5%24.2%17.8%17.9%40.6%17.9%13.5%14.0%13.6%7.7%8.3%14.3%16.9%8.8%14.8%12.1%15.6%9.2%11.4%14.8%13.2%13.8%-
Effective Tax Rate10.3%5.1%43.6%22.8%20.5%29.1%23.9%24.9%16.5%18.7%24.7%21.6%24.6%24.3%32.0%94.4%14.9%0.5%--27.4%33.3%-31.5%
EBITDA1,3028691,1408287051,23058444634532736622721424018510115210870.40-16419717565.00-
EBITDA Margin29.9%23.3%33.2%27.9%28.3%52.9%28.5%23.5%20.5%22.6%27.7%18.4%19.6%23.1%18.6%10.8%17.6%15.3%10.2%-20.4%21.8%20.2%7.4%-
EBIT1,1877911,0587576401,16152139328727130717215918312945.3010667.5013.00-23811393.00-15.00127
EBIT Margin27.3%21.3%30.8%25.5%25.6%50.0%25.5%20.7%17.1%18.7%23.2%13.9%14.6%17.6%12.9%4.9%12.3%9.6%1.9%-29.7%12.5%10.8%-1.7%15.2%